Taking cues from global indices, Sensex zoomed up during today’s morning trade, however, settled at the level of 31,453.51 by the end of the day, which is a drop by 261.84 points or 0.83 per cent than its previous close. Subsequently, Nifty fell by 0.95 per cent, which is 87.90 points to the level of 9,205.60.

The rating committee of ICRA, after due consideration, has reaffirmed the long-term rating for the captioned line of credit (LOC) of Philips Carbon Black limted at [ICRA] AA-.  The outlook on the long-term rating is revised from positive to stable.

Tata Consultancy Services (TCS), a leading global IT services, consulting and business solutions organisation, announced today the launch of TCS WaferWise, a cloud-based wafer anomaly detection solution to help chip makers digitally reimagine their product quality assurance process

PAT jumped by 50 per cent on YoY basis to Rs 60.06 crore as against Rs 40.04 crore in the corresponding quarter last year. This jump was supported by the exceptional item amounting to Rs 66.53 crore for the current quarter, representing provision for impairment in the value of certain plants and equipment, glass bottles & plastic shells.

The market opened in the green on May 5, 2020. The previous trading session witnessed the Sensex going down by 5.9 percent to end at 31,715 and the Nifty was down 5.7 percent to close at 9,293.

The market opened in the green on May 5, 2020. The previous trading session witnessed the Sensex going down by 5.9 percent to end at 31,715 and the Nifty was down 5.7 percent to close at 9,293.

The market opened in the green on May 5, 2020. The previous trading session witnessed the Sensex going down by 5.9 percent to end at 31,715 and the Nifty was down 5.7 percent to close at 9,293.

The market opened in the green on May 5, 2020. The previous trading session witnessed the Sensex going down by 5.9 percent to end at 31,715 and the Nifty was down 5.7 percent to close at 9,293.

Lupin informed the bourses about the positive top-line results from its pivotal Phase 3 clinical trial to assess the efficacy and safety of single-dose Solosec (Secnidazole)

Indian multinational banking and financial services company, ICICI Bank Limited, announced that its board would consider the issue of fundraising via debt securities, this week.